Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


suck pdf from google scholar
unlimited free pdf from europmc34867978    free
PDF from PMC    free
html from PMC    free
PDF vom PMID34867978 :   free

suck abstract from ncbi

Nephropedia Template TP Text

Twit Text FOAVip

Twit Text #

English Wikipedia

  • Effects of beta-Blockers on the Sympathetic and Cytokines Storms in Covid-19 #MMPMID34867978
  • Al-Kuraishy HM; Al-Gareeb AI; Mostafa-Hedeab G; Kasozi KI; Zirintunda G; Aslam A; Allahyani M; Welburn SC; Batiha GE
  • Front Immunol 2021[]; 12 (ä): 749291 PMID34867978show ga
  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a causative virus in the development of coronavirus disease 2019 (Covid-19) pandemic. Respiratory manifestations of SARS-CoV-2 infection such as acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) leads to hypoxia, oxidative stress, and sympatho-activation and in severe cases leads to sympathetic storm (SS). On the other hand, an exaggerated immune response to the SARS-CoV-2 invasion may lead to uncontrolled release of pro-inflammatory cytokine development of cytokine storm (CS). In Covid-19, there are interactive interactions between CS and SS in the development of multi-organ failure (MOF). Interestingly, cutting the bridge between CS and SS by anti-inflammatory and anti-adrenergic agents may mitigate complications that are induced by SARS-CoV-2 infection in severely affected Covid-19 patients. The potential mechanisms of SS in Covid-19 are through different pathways such as hypoxia, which activate the central sympathetic center through carotid bodies chemosensory input and induced pro-inflammatory cytokines, which cross the blood-brain barrier and activation of the sympathetic center. beta2-receptors signaling pathway play a crucial role in the production of pro-inflammatory cytokines, macrophage activation, and B-cells for the production of antibodies with inflammation exacerbation. beta-blockers have anti-inflammatory effects through reduction release of pro-inflammatory cytokines with inhibition of NF-kappaB. In conclusion, beta-blockers interrupt this interaction through inhibition of several mediators of CS and SS with prevention development of neural-cytokine loop in SARS-CoV-2 infection. Evidence from this study triggers an idea for future prospective studies to confirm the potential role of beta-blockers in the management of Covid-19.
  • |Adrenergic beta-Antagonists/*therapeutic use[MESH]
  • |Anti-Inflammatory Agents/therapeutic use[MESH]
  • |COVID-19/complications/*drug therapy/metabolism/physiopathology[MESH]
  • |Catecholamines/metabolism[MESH]
  • |Cytokine Release Syndrome/*drug therapy/etiology/metabolism/physiopathology[MESH]
  • |Cytokines/metabolism[MESH]
  • |Humans[MESH]
  • |Neuroinflammatory Diseases/drug therapy/etiology/metabolism/physiopathology[MESH]
  • |SARS-CoV-2/pathogenicity[MESH]
  • |Sympathetic Nervous System/*drug effects/metabolism/physiopathology[MESH]

  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    749291 ä.12 2021